SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-09-056411
Filing Date
2009-03-17
Accepted
2009-03-17 13:17:53
Documents
3
Period of Report
2009-03-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 20737
2 PRESS RELEASE, ISSUED BY PDL BIOPHARMA, INC. ON MARCH 11, 2009 dex991.htm EX-99.1 5181
3 GRAPHIC g16764g31a23.jpg GRAPHIC 7585
  Complete submission text file 0001193125-09-056411.txt   38247
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 09687271
SIC: 2836 Biological Products, (No Diagnostic Substances)